Need the quick take? I'll walk you through this bill.

Congress.wiki Alpha

Color Theme:

About How Congress Works Support Us Roadmap Privacy Policy Terms of Service

This is not an official government website.

Copyright © 2026 PLEJ LC. All rights reserved.

Increasing Transparency in Generic Drug Applications Act (S-775) · Congress.wiki

Recorded Votes

Recorded roll calls only

0 recorded

No recorded votes yet

Text Versions

No Text Versions

Related Legislation

What do you think?

Amendments

No Amendments

Sponsors (4)

House Votes

Vote Data Not Available

Senate Votes

Pending Committee

March 14, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Presidential Signature

Signature Data Not Available

All LegislationSenate Bill 775S 775

Increasing Transparency in Generic Drug Applications Act

senate
house
president

Introduced March 14, 2023 by Margaret Wood Hassan · Last progress March 14, 2023

AI Summary

No AI Summary available yet

Washingtonrepresentative·Cathy McMorris Rodgers

Lower Costs, More Transparency Act

house

Bill

senate

president

3 cosponsors·Updated 3/3/2026·Last progress December 11, 2023

Floridarepresentative·Neal Patrick Dunn

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

house

Bill

senate

president

1 cosponsor·Updated 3/3/2026·Last progress June 6, 2023

Washingtonrepresentative·Cathy McMorris Rodgers

PATIENT Act of 2023

house

Bill

senate

president

88 cosponsors·Updated 3/3/2026·Last progress May 22, 2023

Minnesotasenator·Tina Smith

Expanding Access to Low-Cost Generics Act of 2023

senate

Bill

house

president

1 cosponsor·Updated 3/3/2026·Last progress March 30, 2023

Action History

IntroReferralMarch 14, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
IntroReferralMarch 14, 2023
Introduced in Senate